Endo International buy krebskrebs
Start price
21.02.22
/
50%
€2.62
Target price
21.02.23
€4.00
Performance (%)
-93.12%
End price
22.02.23
€0.18
Summary
This prediction ended on 22.02.23 with a price of €0.18. Massive losses of -93.12% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endo International | - | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by krebskrebs for this prediction
In the thread Endo International diskutieren
Buy mit Kursziel 4,0
In the thread Trading Endo International
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

